Abstract: This invention presents a cigarette lighter. The cigarette lighter has a lighter body and a golf green repair tool mounted on the lighter body. The golf green repair tool can slide between an extended position and a retracted position. The cigarette lighter also has a golf ball marker seat. A golf ball marker can be removeably mounted in the golfball marker seat.

Abstract: A reusable holder for contact lens cases includes a base, at least one receptacle formed in the base configured to receive a contact lens case, and a time keeping device formed in the base. The time keeping device may include an indicator for the at least one receptacle that indicates a period of time that has lapsed since the contact lens case currently in the at least one receptacle was placed therein to denote a need to discard the contact lens case and a contact lens associated with the contact lens case.

Abstract: Retroreflective material is used to create security features in secure documents. Retroreflective material in the document or sheets used for document creation is laser engraved to create optically variable images, identification quality grayscale images, different directional images viewable at corresponding angles of incidence, multidimensional images, and floating images. High refractive index glass beads are selectively applied to areas of a document surface using a variety of techniques. The beads may be applied in the form of a pre-determined or personalized pattern.

Abstract: An electric motor includes a magnetic field induction device and an induced field device, rotating relative to one another, wherein the induction device comprises a set of two conducting coils around an axis, through which currents travel in the same direction, and a central part, placed between the two coils, comprising a superconducting element placed in a plane that is inclined relative to the axis of the coils, channeling the magnetic field produced by the coils on either side of the inclined plane.

Abstract: The present invention relates to compounds of formula (I) wherein R1, R2 and R3 are as defined in the description, to their pharmaceutical compositions and use thereof for the treatment of cancer expressing oncogenic ALK protein, particularly anaplastic large cell lymphoma (ALCL), diffuse large B cell lymphoma (DLBCL), inflammatory myofibroblastic tumours (IMT) and non-small cell lung cancer (NSCLC).

Abstract: A divider for keeping current-carrying conductors separated transversely in raceways, such as walker ducts and cable trays, in which multiple conductors extend, in order that air can flow around the conductors and cool the conductors. The divider is mounted in the raceway to form passages through which some of the conductors can extend spaced from other conductors. Two separators are mounted together and preferably mounted to the raceway sidewall, forming at least a base passage between the separator and the sidewall of the raceway, and an elevated passage between the walls of the separators.

Abstract: An elastic multiple component fiber comprising a cross-section, wherein at least a first region of said cross-section comprises a polyurethaneurea composition; and comprising a second region.

Abstract: The present invention relates to identification documents and smart cards. In one implementation, we provide a contactless smart identification document comprising a first contact layer, a second contact layer, and a carrier layer. The carrier layer is sandwiched in between the first and second contact layers, and the carrier layer includes least a transceiver and electronic circuitry. At least a portion of the first and second contact layers migrate into the carrier layer.

Abstract: A transmission cable assembly is connected between an ignition coil and a spark plug to transmit a high voltage generated by the ignition coil to the spark plug for ignition of a fuel-air mixture. The transmission cable assembly includes a transmission cable and a grounding unit. The transmission cable includes a high-voltage wire for transmission of high voltage and an insulation jacket wrapped around an outside surface of the high-voltage wire. The grounding unit is made of an electrically conductive substance and includes a grounding layer and multiple grounding wires. The grounding layer completely covers and tightly engages the insulation jacket. The grounding wires each have an end connected to an inside surface of the grounding layer.

Abstract: The present invention provides identification documents with security features. For example, a document may include two or more inks that are designed to cohesively fail upon a de-lamination attack. A resulting failure pattern is preferably difficult to predict. The two or more inks are applied to an identification document including a core and laminate layer. At least one of the inks is characterized such that an adhesive strength of the ink to the core and an adhesive strength of the ink to the laminate layer is each greater than the cohesive strength of the ink itself. Thus, the ink rips apart in a somewhat random-like manner upon a de-lamination attack. The ink can be arranged in interwoven or interlocking patterns or in other desired patterns and locations.

Abstract: A method for treating and/or ameliorating and/or preventing a disease or a disorder, the method comprising administering to an individual in need thereof at least one nitrogen heterocycle derivative of formula (I): The at least one nitrogen heterocycle derivative may also be used as a proteasome activity modulator in the manufacture of a pharmaceutical composition intended to prevent and/or treat a disease condition mediated by the proteasome activity.

Abstract: The invention relates to methods for identifying genes involved in TRAIL-induced apoptosis, to inhibitors of the expression of genes inducing resistance of cells to TRAIL-induced apoptosis and to activators of the expression of a gene sensitizing cells to TRAIL-induced apoptosis. The invention also relates to methods for sensitizing cells to TRAIL-induced apoptosis, methods for treating hyperproliferative diseases, methods for determining the responsiveness of a subject suffering from a hyperproliferative disease to TRAIL, to pharmaceutical compositions comprising products capable of sensitizing cells to TRAIL-induced apoptosis, and to methods for determining the prognosis of a subject suffering from a hyperproliferative disease.

Abstract: The disclosure relates to an image processing method for estimating a brain shift in a patient, the method involving: the processing of a three-dimensional image of the brain of a patient, acquired before a surgical operation, in order to obtain a reference cerebral arterial tree structure of the patient; the processing of three-dimensional images of the brain of the patient, acquired during the operation, in order to at least partially reconstitute a current cerebral arterial tree structure of the patient; the determination from the combination of the reference and current cerebral arterial tree structures, of a field of shift of the vascular tree representing the shift of the current vascular tree in relation to the reference vascular tree; the application of the determined field of shift of the vascular tree to a biomechanical model of the brain of the patient in order to estimate the brain shift of the patient; and the generation, from the estimated brain shift, of at least one image of the brain of the p

Abstract: In order to protect a substrate having at least a portion adjacent to a surface that is made of a refractory material containing silicon, while the substrate is in use at high temperature in a medium that is oxidizing and wet, there is formed on the surface of the substrate an environmental barrier that contains no boron and that has at least one layer that is essentially constituted by a system of oxides formed by at least one rare earth oxide, silica, and alumina, and that is capable of self-healing by maintaining the presence of at least one solid phase in a temperature range extending up to at least 1400° C. approximately.

Abstract: An identification document includes a lens system and a specially prepared photo of a document bearer. The lens system and the specially prepared photo cooperate to create a three dimensional photo effect. The document includes two or more document layers. There is a lens structure in one of the document layers, and it includes lens elements. A photo is printed on one or more of the document layers. The photo depicts the document bearer, and includes two or more separate images of the bearer from different perspectives. Parts of the separate images are interleaved together into sets, and the sets are positioned relative to corresponding lens elements of the lens structure. These sets include parts of the separate images such that when viewed through the lens structure, the parts are viewed simultaneously making the subject appear three-dimensional to a viewer.

Abstract: The invention relates to identification documents, and in particular to providing optically variable personalized data to identification documents. In one implementation, we provide an identification document comprising a document layer and a first indicium. The document layer comprises a material capable of being printed by a thermally transferable optically variable ink. The first indicium is printed on the document layer and comprises personalized data and printed to the document layer by a thermally transferred optically variable ink. The first indicium may be printed to the document layer by disposing a thermally transferable optically variable ink in a mass transfer panel of a printer ribbon adapted for use in a dye diffusion thermal transfer printer, and printing the first indicium as part of a mass transfer printing process.

Abstract: The invention relates to the use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions, specifically to the use of at least one compound derived from para-coumaric acid having a general formula (I) below: in which, especially, Z represents an oxygen or an —NH— group; X and Y are identical and each represent a CH or CH2 group, as an active principle with depigmenting, free-radical-scavenging and/or antiinflammatory is activity. The invention also relates to the use of the above compounds for cosmetic care or for the preparation of a pharmaceutical composition, especially for depigmenting an area of skin, having antiradical and/or antiinflammatory activity.

Abstract: An identification document manufacturing method makes an identification document with an optically variable security feature by forming a lens structure in the document's lamination layer along with image information. The method provides image information arranged to include at least two different images. The method uses pressure to form a lens profile in a laminate, including combining the laminate with ink representing the image information to form the document. The document is formed together with the laminate and ink such that the lens profile enables display of the at least two different images when the document is viewed at different predetermined angles. An information bearing document comprises a core layer, an image layer depicting at least two different images, and a laminate layer. The laminate layer is pressed on the core layer such that it forms a lens profile that enables display of the at least two different images when the document is viewed at different predetermined angles.

Abstract: The subject matter of the present disclosure relates to an in vitro method for the screening of anti-cancer compounds based on the capacity for these compounds to interact with neurotrophin 3 (NT-3 or NT3), to the extracellular domain, or TrkC receptor and/or to inhibit the dimerization of the intracellular domain of the TrkC receptor expressed in tumor cells, particularly in neuroblastoma. The disclosure also relates to a method for predicting the presence of metastatic cancer or a bad prognosis cancer, or for determining the efficiency of an anti-cancer treatment based on the measuring of the expression level of neurotrophin 3. The disclosure further comprises kits and compounds as a medicament for the treatment of neuroblastoma or cancer overexpressing neurotrophin 3 by the tumor cells.